This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes
- Quo Vadis, Molecular Imaging?
- Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
- Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
- {alpha}-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies--Part 2
- Cerenkov Radiation-Induced Photoimmunotherapy with 18F-FDG
- Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers
- In Vivo 3-Dimensional Radiopharmaceutical-Excited Fluorescence Tomography
- Optical Imaging of Ionizing Radiation from Clinical Sources
- Cerenkov Luminescence Imaging for Radiation Dose Calculation of a 90Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist
- Cerenkov-Specific Contrast Agents for Detection of pH In Vivo
- Intratherapeutic Biokinetic Measurements, Dosimetry Parameter Estimates, and Monitoring of Treatment Efficacy Using Cerenkov Luminescence Imaging in Preclinical Radionuclide Therapy
- Cerenkov Luminescence Endoscopy: Improved Molecular Sensitivity with {beta}--Emitting Radiotracers
- In Vivo Localization of 90Y and 177Lu Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model
- Clinical Cerenkov Luminescence Imaging of 18F-FDG
- Designing the Magic Bullet? The Advancement of Immuno-PET into Clinical Use
- Intraoperative Imaging of Tumors Using Cerenkov Luminescence Endoscopy: A Feasibility Experimental Study
- Positron Lymphography: Multimodal, High-Resolution, Dynamic Mapping and Resection of Lymph Nodes After Intradermal Injection of 18F-FDG
- Proof-of-Concept Study of Monitoring Cancer Drug Therapy with Cerenkov Luminescence Imaging
- Harnessing the Power of Radionuclides for Optical Imaging: Cerenkov Luminescence Imaging
- Multimodal Imaging with 18F-FDG PET and Cerenkov Luminescence Imaging After MLN4924 Treatment in a Human Lymphoma Xenograft Model
- Novel insights on imaging sex hormone-dependent tumourigenesis in vivo